Phenotypic clusters of patients with Takayasu arteritis predict disease activity at presentation, damage and future

Aysegul Avcu1, Augustine Jose2, Sachit Ganapathy3

  • 1Division of Rheumatology, Department of Internal Medicine, Marmara University, School of Medicine, Istanbul, Türkiye.

PubMed

Insights

This study identified three distinct patient clusters for Takayasu arteritis (TAK) based on clinical and angiographic features. These clusters show varying disease patterns and prognoses, aiding in personalized treatment strategies for TAK.

Area of Science:

  • Rheumatology
  • Vascular Medicine
  • Immunology

Background:

  • Takayasu arteritis (TAK) is a rare, chronic inflammatory condition affecting large arteries.
  • Understanding TAK heterogeneity is crucial for predicting disease course and outcomes.

Purpose of the Study:

  • To identify distinct patient clusters in Takayasu arteritis (TAK) using clinical and angiographic data.
  • To evaluate the prognostic relevance of these identified TAK clusters.

Main Methods:

  • Agglomerative hierarchical clustering was applied to phenotype data from 564 TAK patients across three cohorts.
  • Clinical features, angiographic involvement, disease activity, Vasculitis Damage Index (VDI), treatment initiation, vascular procedures, and complications were analyzed.
  • Mortality rates were assessed using Cox regression analysis.

Main Results:

  • Three primary clusters (1, 2, with sub-clusters 2A, 2B) were identified, differing in age, sex distribution, and affected arterial segments.
  • Cluster 2A showed less severe disease with lower rates of medication initiation and complications compared to Cluster 1.
  • Cluster 2B exhibited more extensive disease, higher VDI, and increased need for vascular interventions.
  • Overall survival rates were similar across all identified clusters.

Conclusions:

  • Phenotypic clustering of Takayasu arteritis patients reveals distinct patterns of angiographic involvement.
  • These identified clusters possess prognostic implications, potentially guiding tailored therapeutic approaches for TAK.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
474
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
500
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
364
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
303
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
925
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
890